Compare Johnson & Johnson (JNJ) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs United Parcel Service Inc — how do they compare? Johnson & Johnson trades at $259.22 (market cap $618.09B), while United Parcel Service Inc trades at $94.6 (market cap $80.08B). The key difference: Johnson & Johnson is far larger — about 7.7× United Parcel Service Inc's market cap, and United Parcel Service Inc pays the higher dividend (6.97%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and United Parcel Service Inc for 141 Days on average.
| JNJ | UPS | |
|---|---|---|
Market Cap | $618.09B | $80.08B |
Volume | 6,050,983 | 6,706,833 |
Sector | Health | Industrials |
52-Week High | $278.43 | $120.00 |
52-Week Low | $186.00 | $82.87 |
Typical Hold Time | 129 Days | 141 Days |
Enterprise Value | $646.37B | $104.10B |
Dividend Yield | 2.09% | 6.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $258.45, up 1.44% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and robust cash flow. Analyst consensus is bullish with a $286.53 price target, though technical indicators show resistance near $260. Recent news highlights pipeline strength including Icotyde's potential $4.5B peak sales.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and competitive pressures. The stock presents value near current levels with 10.7% upside to consensus target, though technical weakness suggests potential near-term consolidation. Long-term growth drivers include oncology portfolio and Ottava surgical system development.
UPS stock trades at $92.28, down 0.89% amid bearish technical signals and mixed fundamentals. The company maintains strong profitability with 29.66% ROE and has beaten earnings estimates for three consecutive quarters. Recent developments include the launch of UPS Secure Commerce and an exclusive TikTok Shop partnership, while facing headwinds from fuel costs and volume pressures. Analyst consensus remains positive with a $118.67 price target representing 29% upside potential.
The investment case balances attractive valuation metrics (P/E 17.5, P/S 0.89) against declining revenue trends and competitive threats. The 7% dividend yield provides income support, but investors face risks from margin compression and Amazon competition. Wall Street sentiment leans bullish despite recent price weakness, with improving domestic margins seen as the key catalyst.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
